IP Library › Granted Patent US 7,968,602
Granted Patent B2
US 7,968,602 · App. 12/533,354 · Granted Jun 28, 2011

4-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid analogs and method of manufacture and use thereof

Assignees: Wisconsin Alumni Research Foundation; University of California-Los Angeles; Ohio State Research Foundation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,968,602
App. No.
12/533,354
Granted
Jun 28, 2011
Kind
B2
Abstract

Analogs of 4-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-napthalenyl)-1-propenyl]benzoic acid and methods of manufacture and use thereof, such as for use in cancer prevention and treatment.

Claims (4)

1. A compound according to the formula

and salts and solvates thereof.

2. A method for treating breast cancer in a human comprising administering to the human a therapeutically effective amount of a compound selected from the group consisting of

and salts and solvates thereof.

Assignments (1)
CONFIRMATORY LICENSE Recorded Oct 5, 2010
From: WISCONSIN ALUMNI RESEARCH FOUNDATION
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025092/0628 →
Continuity (3)
Continuation 11428165 · Jun 30, 2006
Provisional Application 60695564 · Jun 30, 2005
Related Publication 20100029777A1 · Feb 4, 2010